
Oriental Aromatics Q2 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 4- The Fragrance and Flavor division is showing robust growth with new product launches, new customer wins, and expansion in all markets.
- Volume requirements for the First Half of 2024 are much better compared to H2-2023, indicating improved demand.
- Current revenue remains somewhat stagnant, but expansions at Mahad and Baroda facilities are expected to change the revenue mix and contribute to growth.
- Focus on profitable products and expansion in bulk and specialty aroma chemicals is expected to increase both volume and value.
- Camphor division volumes remain stable despite pricing pressure, with full capacity utilization at the Bareilly plant.
- Overall, steady state demand is anticipated with expanding contribution from specialty and bulk aroma chemicals, supporting future top-line growth.
See what Oriental Aromatics management said on margin guidance — free account, 30 seconds.
Fundraise plans
- There is no mention of any current or future fundraising through debt or equity in the provided transcript.
- The company discussed ongoing CAPEX plans, including expansions at Mahad and Baroda facilities and a hydrogenation facility commissioning, but no details on financing these through fundraising were provided.
- Net debt-equity ratio stands at 0.33 as of 30th September 2023, indicating manageable leverage.
- No direct references to plans for new debt or equity issuance were discussed during the Q&A or management comments.
See what Oriental Aromatics management said on order book — free account, 30 seconds.
Capex plans
Yes- The company has ongoing CAPEX plans which have been slightly downsized to ensure sustained profitability.
- The hydrogenation facility at Baroda has been optimized and is scheduled to be commissioned in Q4 FY24.
- The Mahad investment project is on track in terms of both timeline and budget.
- Expansion projects at Mahad and Baroda are expected to impact the revenue mix in the future, with a larger contribution anticipated from Specialty and Bulk Aroma Chemicals.
- Regarding new plants going live, it is still too early to confirm whether these are fully operational or at trial batch stages, with trial batches and approvals typically taking around six months.
Track Oriental Aromatics — get its next earnings analysis in your feed
How does Oriental Aromatics rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Oriental Aromatics rank in Chemicals & Petrochemicals?
Compare Oriental Aromatics against every Chemicals & Petrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Oriental Aromatics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…